The outlook of companies tied to iconic drugs like Viagra presents a complex investment scenario . While the initial surge of copyright, fueled by Viagra's remarkable popularity, generated substantial returns, the loss of exclusivity in key territories has introduced significant uncertainty . Investors are now grappling with the impact of lower-cos